Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  AngioDynamics, Inc.    ANGO

ANGIODYNAMICS, INC. (ANGO)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

AngioDynamics, Inc. : half-yearly earnings release

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/01/2018 | 03:15pm CET

The company will report its earnings for S1 2018 on 01/04/2018. Generally, the company reports earnings worse than estimates. In recent months, the 3 analysts from Thomson Reuters consensus have not revised their EPS estimates.


© 4-traders.com 2018
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ANGIODYNAMICS, INC.
01/10 ANGIODYNAMICS INC : Regulation FD Disclosure, Financial Statements and Exhibits ..
01/05 ANGIODYNAMICS : Management's Discussion and Analysis of Financial Condition and ..
01/04 ANGIODYNAMICS, INC. (NASDAQ : ANGO) Files An 8-K Regulation FD Disclosure
01/04 ANGIODYNAMICS, INC. (NASDAQ : ANGO) Files An 8-K Results of Operations and Finan..
01/04 ANGIODYNAMICS (NASDAQ : ANGO) reported earnings of $0.16 per share meeting Walls..
01/04 ANGIODYNAMICS INC : Results of Operations and Financial Condition, Financial Sta..
01/01ANGIODYNAMICS, INC. : half-yearly earnings release
2017 ANGIODYNAMICS : to Report Fiscal 2018 Second Quarter Financial Results on Januar..
2017 ANGIODYNAMICS : to Present at the J.P. Morgan Healthcare Conference
2017 ANGIODYNAMICS : to Report Fiscal 2018 Second Quarter Financial Results on Januar..
More news
News from SeekingAlpha
01/11 AngioDynamics (ANGO) Presents At 36th Annual J.P. Morgan Healthcare Conferenc..
01/05 Premarket analyst action - healthcare
01/04 AngioDynamics' (ANGO) CEO Jim Clemmer on Q2 2018 Results - Earnings Call Tran..
01/04 AngioDynamics, Inc. 2018 Q2 - Results - Earnings Call Slides
01/04 AngioDynamics revenues off 3%; non-GAAP EPS down 16% in Q2; updates guidance
Financials ($)
Sales 2018 347 M
EBIT 2018 37,5 M
Net income 2018 12,3 M
Debt 2018 13,0 M
Yield 2018 -
P/E ratio 2018 59,20
P/E ratio 2019 23,97
EV / Sales 2018 1,77x
EV / Sales 2019 1,58x
Capitalization 601 M
Chart ANGIODYNAMICS, INC.
Duration : Period :
AngioDynamics, Inc. Technical Analysis Chart | ANGO | US03475V1017 | 4-Traders
Technical analysis trends ANGIODYNAMICS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 5
Average target price 16,2 $
Spread / Average Target -1,3%
EPS Revisions
Managers
NameTitle
James C. Clemmer President, Chief Executive Officer & Director
Howard W. Donnelly Chairman
Barbara Kucharczyk Senior Vice President-Global Operations
Michael C. Greiner Chief Financial Officer & Executive Vice President
Jeffrey G. Gold Independent Director
Sector and Competitors